Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zafirlukast (ICI 204219) is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 9,500 | |||
50 mg | 在庫あり | ¥ 13,500 | |||
100 mg | 在庫あり | ¥ 19,500 | |||
200 mg | 在庫あり | ¥ 35,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,500 |
説明 | Zafirlukast (ICI 204219) is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma. |
別名 | Vanticon, ICI 204219, Accolate |
分子量 | 575.68 |
分子式 | C31H33N3O6S |
CAS No. | 107753-78-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (95.54 mM)
5% DMSO+95% Saline: 4.65 mg/mL (8.08 mM, suspension)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zafirlukast 107753-78-6 GPCR/G Protein Leukotriene Receptor ICI204219 Vanticon ICI-204219 ICI 204219 Inhibitor inhibit Accolate inhibitor